Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education: A Randomized Controlled Trial Focusing on HbA1c and Glucose Variability in Patients With Type 2 Diabetes (The BCC Study)
Verified date | April 2023 |
Source | Steno Diabetes Center Copenhagen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study is to examine the health benefits of adding a concept in basic carbohydrate counting (BCC) to the routine outpatient nutritional education for adult patients with type 2 diabetes. The study hypothesis is that training and education in the BCC concept will improve glycaemic control either by reducing HbA1c or the average plasma glucose variability more than offering the routine dietary care as a stand-alone dietary treatment.
Status | Completed |
Enrollment | 48 |
Est. completion date | August 16, 2022 |
Est. primary completion date | August 16, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - Type 2 diabetes - Diabetes duration; from >12 months - HbA1c between 53 and 97 mmol/mol - Diet or any glucose-lowering medication - Provided voluntary written informed consent Exclusion Criteria: - Practicing carbohydrate counting, as judged by the investigator - Participated in a BCC group program within the last two years - Low daily intake of carbohydrates (defined as below 25 E% or 100 g/day), as judged by the investigator - Use of open CGM - Use of a Free Libre device - Use of an automated bolus calculator for carbohydrate counting, as judged by the investigator - Gastroparesis - Pregnancy or breastfeeding, or plans of pregnancy within the study period - Uncontrolled medical issues, as judged by the investigator - Concomitant participation in other clinical studies - Unable to understand the informed consent and the study procedures |
Country | Name | City | State |
---|---|---|---|
Denmark | Steno Diabetes Center Copenhagen | Herlev |
Lead Sponsor | Collaborator |
---|---|
Steno Diabetes Center Copenhagen | University of Copenhagen |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in physical activity level | total score or percent (%) | Baseline, 6 months, 12 months | |
Other | Change in urinary biomarkers of carbohydrate intake | percent (%) | Baseline, 6 months | |
Primary | Change in HbA1c | mmol/mol | Baseline, 6 months | |
Primary | Change in mean amplitude of glycaemic excursions (MAGE) | mmol/l | Baseline, 6 months | |
Secondary | Change in HbA1c | mmol/mol | 12 months | |
Secondary | Change in body weight | kg | Baseline, 6 months, 12 months | |
Secondary | Change in low-density lipoprotein cholesterol (LDL-C) | mmol/l | Baseline, 6 months, 12 months | |
Secondary | Change in high-density cholesterol (HDL-C) | mmol/l | Baseline, 6 months, 12 months | |
Secondary | Change in total cholesterol (TC) | mmol/l | Baseline, 6 months, 12 months | |
Secondary | Change in free fatty acids (FFA) | mmol/l | Baseline, 6 months, 12 months | |
Secondary | Change in triglycerides (TG) | mmol/l | Baseline, 6 months, 12 months | |
Secondary | Change in diastolic blood pressure | mm Hg | Baseline, 6 months, 12 months | |
Secondary | Change in systolic blood pressure | mm Hg | Baseline, 6 months, 12 months | |
Secondary | Change in waist circumference | cm | Baseline, 6 months, 12 months | |
Secondary | Change in hip circumference | cm | Baseline, 6 months, 12 months | |
Secondary | Change in total fat free mass | gram | Baseline, 6 months | |
Secondary | Change in total fat mass | gram | Baseline, 6 months | |
Secondary | Change in time in range (3.9-10.0 mmol/l) | percent (%) | Baseline, 6 months | |
Secondary | Changes in time spent in hypoglycaemia (<3.9 mmol/l) | percent (%) | Baseline, 6 months | |
Secondary | Change time spent in hyperglycaemia (e.g. >11.1 mmol/l) | percent (%) | Baseline, 6 months | |
Secondary | Change in standard deviation of mean plasma glucose | mmol/l | Baseline, 6 months | |
Secondary | Change in mathematical literacy | total score or percent (%) | Baseline, 6 months, 12 months | |
Secondary | Change in carbohydrate estimation accuracy | total score or % | Baseline, 6 months, 12 months | |
Secondary | Change in diet-related quality of life | total score or percent (%) | Baseline, 6 months, 12 months | |
Secondary | Change in perceived competences in diabetes | total score or percent (%) | Baseline, 6 months, 12 months | |
Secondary | Change in degree of autonomy-supportive dietitian | total score or percent (%) | Baseline, 6 months, 12 months | |
Secondary | Change in total energy intake | kJ/day | Baseline, 6 months | |
Secondary | Change in dietary intake of carbohydrates | gram/day or percent of total energy (E%) | Baseline, 6 months | |
Secondary | Change in dietary intake of total fat | gram/day or percent of total energy (E%) | Baseline, 6 months | |
Secondary | Change in dietary intake of saturated fatty acids (SFA) | gram/day or percent of total energy (E%) | Baseline, 6 months | |
Secondary | Change in dietary intake of monounsaturated fatty acids (MUFA) | gram/day or percent of total energy (E%) | Baseline, 6 months | |
Secondary | Change in dietary intake of polyunsaturated fatty acids (PUFA) | gram/day or percent of total energy (E%) | Baseline, 6 months | |
Secondary | Change in dietary intake of protein | gram/day or percent of total energy (E%) | Baseline, 6 months | |
Secondary | Change in dietary intake of added sugar | gram/day , % of total energy or % | Baseline, 6 months | |
Secondary | Change in intake of dietary fibre | gram/day or g/MJ | Baseline, 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |